Engineering protein self-assembling in protein-based nanomedicines for drug delivery and gene therapy

References

• Anderson DH, Kickhoefer VA, Sievers SA, et al. (2007). Draft crystal structure of the vault shell at 9-A resolution. PLoS Biol, 5, e318
   Google Scholar
• Aris A, Villaverde A. (2000). Molecular organization of protein-DNA complexes for cell-targeted DNA delivery. Biochem Biophys Res Commun, 278, 455–61
   PubMed Web of Science ®Google Scholar
• Aris A, Villaverde A. (2003). Engineering nuclear localization signals in modular protein vehicles for gene therapy. Biochem Biophys Res Commun, 304, 625–31
   PubMed Web of Science ®Google Scholar
• Aris A, Villaverde A. (2004). Modular protein engineering for non-viral gene therapy. Trends Biotechnol, 22, 371–7
   PubMedGoogle Scholar
• Bennett J, Ashtari M, Wellman J, et al. (2012). AAV2 gene therapy readministration in three adults with congenital blindness. Sci Transl Med, 4, 120ra15
   PubMed Web of Science ®Google Scholar
• Bobik TA. (2006). Polyhedral organelles compartmenting bacterial metabolic processes. Appl Microbiol Biotechnol, 70, 517–25
   PubMedGoogle Scholar
• Bobik TA, Havemann GD, Busch RJ, et al. (1999). The propanediol utilization (pdu) operon of Salmonella enterica serovar Typhimurium LT2 includes genes necessary for formation of polyhedral organelles involved in coenzyme B(12)-dependent 1, 2-propanediol degradation. J Bacteriol, 181, 5967–75
   PubMed Web of Science ®Google Scholar
• Cano-Garrido O, Rodriguez-Carmona E, Diez-Gil C, et al. (2013). Supramolecular organization of protein-releasing functional amyloids solved in bacterial inclusion bodies. Acta Biomater, 9, 6134–42
   PubMedGoogle Scholar
• Champion CI, Kickhoefer VA, Liu G, et al. (2009). A vault nanoparticle vaccine induces protective mucosal immunity. PLoS.One, 4, e5409
   PubMed Web of Science ®Google Scholar
• Chawla SP, Chua VS, Fernandez L, et al. (2010). Advanced phase I/II studies of targeted gene delivery in vivo: intravenous rexin-G for gemcitabine-resistant metastatic pancreatic cancer. Mol Ther, 18, 435–41
   PubMed Web of Science ®Google Scholar
• Chen L, Zurita AJ, Ardelt PU, et al. (2004). Design and validation of a bifunctional ligand display system for receptor targeting. Chem Biol, 11, 1081–91
   PubMed Web of Science ®Google Scholar
• Chen P, Andersson DI, Roth JR. (1994). The control region of the pdu/cob regulon in Salmonella typhimurium. J Bacteriol, 176, 5474–82
   PubMed Web of Science ®Google Scholar
• Cheng S, Liu Y, Crowley CS, et al. (2008). Bacterial microcompartments: their properties and paradoxes. Bioessays, 30, 1084–95
   PubMedGoogle Scholar
• Chou MI, Hsieh YF, Wang M, et al. (2010). In vitro and in vivo targeted delivery of IL-10 interfering RNA by JC virus-like particles. J Biomed Sci, 17, 51
   PubMedGoogle Scholar
• Clark JR, March JB. (2006). Bacteriophages and biotechnology: vaccines, gene therapy and antibacterials. Trends Biotechnol, 24, 212–8
   PubMed Web of Science ®Google Scholar
• Corchero JL, Gasser B, Resina D, et al. (2013). Unconventional microbial systems for the cost-efficient production of high-quality protein therapeutics. Biotechnol Adv, 31, 140–53
   PubMed Web of Science ®Google Scholar
• Cot SS, So AK, Espie GS. (2008). A multiprotein bicarbonate dehydration complex essential to carboxysome function in cyanobacteria. J Bacteriol, 190, 936–45
   PubMedGoogle Scholar
• Dalmau M, Lim S, Wang SW. (2009a). Design of a pH-dependent molecular switch in a caged protein platform. Nano Lett, 9, 160–6
   PubMed Web of Science ®Google Scholar
• Dalmau M, Lim S, Wang SW. (2009b). pH-triggered disassembly in a caged protein complex. Biomacromolecules, 10, 3199–206
   PubMedGoogle Scholar
• Dietrich U, Durr R, Koch J. (2012). Peptides as drugs: from screening to application. Curr Pharm Biotechnol, PMID: 22429133. [Epub ahead of print]
   Google Scholar
• Diez-Gil C, Krabbenborg S, Garcia-Fruitos E, et al. (2010). The nanoscale properties of bacterial inclusion bodies and their effect on mammalian cell proliferation. Biomaterials, 31, 5805–12
   PubMed Web of Science ®Google Scholar
• Domingo-Espin J, Vazquez E, Ganz J, et al. (2011). Nanoparticulate architecture of protein-based artificial viruses is supported by protein-DNA interactions. Nanomedicine (Lond), 6, 1047–61
   PubMedGoogle Scholar
• Douglas KL. (2008). Toward development of artificial viruses for gene therapy: a comparative evaluation of viral and non-viral transfection. Biotechnol Prog, 24, 871–83
   PubMed Web of Science ®Google Scholar
• English RS, Jin S, Shively JM. (1995). Use of electroporation to generate a Thiobacillus neapolitanus carboxysome mutant. Appl Environ Microbiol, 61, 3256–60
   PubMedGoogle Scholar
• Esfandiary R, Kickhoefer VA, Rome LH, et al. (2009). Structural stability of vault particles. J Pharm Sci, 98, 1376–86
   PubMedGoogle Scholar
• Espargaro A, Villar-Pique A, Sabate R, Ventura S. (2012). Yeast prions form infectious amyloid inclusion bodies in bacteria. Microb Cell Fact, 11, 89
   PubMedGoogle Scholar
• Fan C, Bobik TA. (2011). The N-terminal region of the medium subunit (PduD) packages adenosylcobalamin-dependent diol dehydratase (PduCDE) into the Pdu microcompartment. J Bacteriol, 193, 5623–8
   PubMedGoogle Scholar
• Fan C, Cheng S, Liu Y, et al. (2010). Short N-terminal sequences package proteins into bacterial microcompartments. Proc Natl Acad Sci USA, 107, 7509–14
   PubMed Web of Science ®Google Scholar
• Fang CY, Lin PY, Ou WC, et al. (2012). Analysis of the size of DNA packaged by the human JC virus-like particle. J Virol Methods, 182, 87–92
   PubMedGoogle Scholar
• Ferrer-Miralles N, Corchero JL, Kumar P, et al. (2011). Biological activities of histidine-rich peptides: merging biotechnology and nanomedicine. Microb Cell Fact, 10, 101
   PubMed Web of Science ®Google Scholar
• Ferrer-Miralles N, Domingo-Espin J, Corchero JL, et al. (2009). Microbial factories for recombinant pharmaceuticals. Microb Cell Fact, 8, 17
   PubMed Web of Science ®Google Scholar
• Ferrer-Miralles N, Vazquez E, Villaverde A. (2008). Membrane-active peptides for non-viral gene therapy: making the safest easier. Trends Biotechnol, 26, 267–75
   PubMed Web of Science ®Google Scholar
• Flenniken ML, Willits DA, Harmsen AL, et al. (2006). Melanoma and lymphocyte cell-specific targeting incorporated into a heat shock protein cage architecture 1. Chem Biol, 13, 161–70
   PubMed Web of Science ®Google Scholar
• Gao CC. (2011). Clinical data of recombinant adeno-viral human p53 gene (rAd-p53), gendicine (R), in treatment of human solid tumors. Hum Gene Ther, 22, A114
   Google Scholar
• Garcia-Fruitos E, Gonzalez-Montalban N, Morell M, et al. (2005). Aggregation as bacterial inclusion bodies does not imply inactivation of enzymes and fluorescent proteins. Microb Cell Fact, 4, 27
   PubMed Web of Science ®Google Scholar
• Garcia-Fruitos E, Martinez-Alonso M, Gonzalez-Montalban N, et al. (2007). Divergent genetic control of protein solubility and conformational quality in Escherichia coli. J Mol Biol, 374, 195–205
   PubMed Web of Science ®Google Scholar
• Garcia-Fruitos E, Sabate R, de Groot NS, et al. (2011). Biological role of bacterial inclusion bodies: a model for amyloid aggregation. FEBS J, 278, 2419–27
   PubMed Web of Science ®Google Scholar
• Garcia-Fruitos E, Seras-Franzoso J, Vazquez E, Villaverde A. (2010). Tunable geometry of bacterial inclusion bodies as substrate materials for tissue engineering. Nanotechnology, 21, 205101
   PubMedGoogle Scholar
• Garcia-Fruitos E, Vazquez E, ez-Gil C, et al. (2012). Bacterial inclusion bodies: making gold from waste. Trends Biotechnol, 30, 65–70
   PubMed Web of Science ®Google Scholar
• Garcia-Fruitos E, Villaverde A. (2010). Friendly production of bacterial inclusion bodies. Korean J Chem Eng, 27, 385–9
   Google Scholar
• García-Fruitós E, Rodríguez-Carmona E, Díez-Gil C, et al. (2009). Surface cell growth engineering assisted by a novel bacterial nanomaterial. Adv Mater, 21, 4249–53
   Web of Science ®Google Scholar
• Gelain F, Unsworth LD, Zhang S. (2010). Slow and sustained release of active cytokines from self-assembling peptide scaffolds. J Control Release, 145, 231–9
   PubMed Web of Science ®Google Scholar
• Giacca M, Zacchigna S. (2012). Virus-mediated gene delivery for human gene therapy. J Control Release, 161, 377–88
   PubMed Web of Science ®Google Scholar
• Gitai Z. (2005). The new bacterial cell biology: moving parts and subcellular architecture. Cell, 120, 577–86
   PubMed Web of Science ®Google Scholar
• Gleiter S, Lilie H. (2001). Coupling of antibodies via protein Z on modified polyoma virus-like particles. Protein Sci, 10, 434–44
   PubMed Web of Science ®Google Scholar
• Goicochea NL, De M, Rotello VM, et al. (2007). Core-like particles of an enveloped animal virus can self-assemble efficiently on artificial templates. Nano Lett, 7, 2281–90
   PubMed Web of Science ®Google Scholar
• Goldsmith LE, Pupols M, Kickhoefer VA, et al. (2009). Utilization of a protein “shuttle” to load vault nanocapsules with gold probes and proteins. ACS Nano, 3, 3175–83
   PubMedGoogle Scholar
• Goldsmith LE, Yu M, Rome LH, Monbouquette HG. (2007). Vault nanocapsule dissociation into halves triggered at low pH. Biochemistry, 46, 2865–75
   PubMedGoogle Scholar
• Gonzalez-Montalban N, Garcia-Fruitos E, Ventura S, et al. (2006). The chaperone DnaK controls the fractioning of functional protein between soluble and insoluble cell fractions in inclusion body-forming cells. Microb Cell Fact, 5, 26
   PubMed Web of Science ®Google Scholar
• Gopinath SC, Matsugami A, Katahira M, Kumar PK. (2005). Human vault-associated non-coding RNAs bind to mitoxantrone, a chemotherapeutic compound. Nucleic Acids Res, 33, 4874–81
   PubMed Web of Science ®Google Scholar
• Guo J, Xin H. (2006). Chinese gene therapy. Splicing out the West? Science, 314, 1232–5
   PubMed Web of Science ®Google Scholar
• Hacein-Bey-Abina S, Von Kalle C, Schmidt M, et al. (2003a). A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med, 348, 255–6
   PubMed Web of Science ®Google Scholar
• Hacein-Bey-Abina S, Von Kalle C, Schmidt M, et al. (2003b). LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science, 302, 415–9
   PubMed Web of Science ®Google Scholar
• Han M, Kickhoefer VA, Nemerow GR, Rome LH. (2011). Targeted vault nanoparticles engineered with an endosomolytic peptide deliver biomolecules to the cytoplasm. ACS Nano, 5, 6128–37
   PubMedGoogle Scholar
• Harbottle RP, Cooper RG, Hart SL, et al. (1998). An RGD-oligolysine peptide: a prototype construct for integrin-mediated gene delivery. Hum Gene Ther, 9, 1037–47
   PubMed Web of Science ®Google Scholar
• Havemann GD, Sampson EM, Bobik TA. (2002). PduA is a shell protein of polyhedral organelles involved in coenzyme B(12)-dependent degradation of 1,2-propanediol in Salmonella enterica serovar typhimurium LT2 2. J Bacteriol, 184, 1253–61
   PubMedGoogle Scholar
• Henke S, Rohmann A, Bertling WM, et al. (2000). Enhanced in vitro oligonucleotide and plasmid DNA transport by VP1 virus-like particles. Pharm Res, 17, 1062–70
   PubMed Web of Science ®Google Scholar
• Hosseinkhani H, Hosseinkhani M, Khademhosseini A, et al. (2006). Enhanced angiogenesis through controlled release of basic fibroblast growth factor from peptide amphiphile for tissue regeneration. Biomaterials, 27, 5836–44
   PubMed Web of Science ®Google Scholar
• Howe SJ, Mansour MR, Schwarzwaelder K, et al. (2008). Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients. J Clin Invest, 118, 3143–50
   PubMed Web of Science ®Google Scholar
• Hsieh PC, Davis ME, Gannon J, et al. (2006). Controlled delivery of PDGF-BB for myocardial protection using injectable self-assembling peptide nanofibers. J Clin Invest, 116, 237–48
   PubMed Web of Science ®Google Scholar
• Kaczmarczyk SJ, Sitaraman K, Young HA, et al. (2011). Protein delivery using engineered virus-like particles. Proc Natl Acad Sci USA, 108, 16998–7003
   PubMed Web of Science ®Google Scholar
• Kang HJ, Kang YJ, Lee YM, et al. (2012). Developing an antibody-binding protein cage as a molecular recognition drug modular nanoplatform. Biomaterials, 33, 5423–30
   PubMed Web of Science ®Google Scholar
• Kaufmann JK, Nettelbeck DM. (2012). Virus chimeras for gene therapy, vaccination, and oncolysis: adenoviruses and beyond. Trends Mol Med, 18, 365–76
   PubMed Web of Science ®Google Scholar
• Kedersha NL, Heuser JE, Chugani DC, Rome LH. (1991). Vaults. III. Vault ribonucleoprotein particles open into flower-like structures with octagonal symmetry. J Cell Biol, 112, 225–35
   PubMed Web of Science ®Google Scholar
• Kedersha NL, Miquel MC, Bittner D, Rome LH. (1990). Vaults. II. Ribonucleoprotein structures are highly conserved among higher and lower eukaryotes. J Cell Biol, 110, 895–901
   PubMed Web of Science ®Google Scholar
• Kedersha NL, Rome LH. (1986). Isolation and characterization of a novel ribonucleoprotein particle: large structures contain a single species of small RNA. J Cell Biol, 103, 699–709
   PubMed Web of Science ®Google Scholar
• Kerfeld CA, Sawaya MR, Tanaka S, et al. (2005). Protein structures forming the shell of primitive bacterial organelles. Science, 309, 936–8
   PubMed Web of Science ®Google Scholar
• Khalaj-Kondori M, Sadeghizadeh M, Behmanesh M, et al. (2011). Chemical coupling as a potent strategy for preparation of targeted bacteriophage-derived gene nanocarriers into eukaryotic cells. J Gene Med, 13, 622–31
   PubMed Web of Science ®Google Scholar
• Kickhoefer VA, Garcia Y, Mikyas Y, et al. (2005). Engineering of vault nanocapsules with enzymatic and fluorescent properties. Proc Natl Acad Sci USA, 102, 4348–52
   PubMed Web of Science ®Google Scholar
• Kickhoefer VA, Rajavel KS, Scheffer GL, et al. (1998). Vaults are up-regulated in multidrug-resistant cancer cell lines. J Biol Chem, 273, 8971–4
   PubMed Web of Science ®Google Scholar
• Kofoid E, Rappleye C, Stojiljkovic I, Roth J. (1999). The 17-gene ethanolamine (eut) operon of Salmonella typhimurium encodes five homologues of carboxysome shell proteins. J Bacteriol, 181, 5317–29
   PubMed Web of Science ®Google Scholar
• Kolli S, Zito CI, Mossink MH, et al. (2004). The major vault protein is a novel substrate for the tyrosine phosphatase SHP-2 and scaffold protein in epidermal growth factor signaling. J Biol Chem, 279, 29374–85
   PubMed Web of Science ®Google Scholar
• Kong LB, Siva AC, Rome LH, Stewart PL. (1999). Structure of the vault, a ubiquitous celular component. Structure, 7, 371–9
   PubMedGoogle Scholar
• Krag DN, Shukla GS, Shen GP, et al. (2006). Selection of tumor-binding ligands in cancer patients with phage display libraries. Cancer Res, 66, 7724–33
   PubMed Web of Science ®Google Scholar
• Kyle S, Aggeli A, Ingham E, McPherson MJ. (2010). Recombinant self-assembling peptides as biomaterials for tissue engineering. Biomaterials, 31, 9395–405
   PubMed Web of Science ®Google Scholar
• Lakshmanan A, Zhang S, Hauser CA. (2012). Short self-assembling peptides as building blocks for modern nanodevices. Trends Biotechnol, 30, 155–65
   PubMedGoogle Scholar
• Lee KW, Tey BT, Ho KL, Tan WS. (2012). Delivery of chimeric hepatitis B core particles into liver cells. J Appl Microbiol, 112, 119–31
   PubMed Web of Science ®Google Scholar
• Lee LA, Nguyen HG, Wang Q. (2011). Altering the landscape of viruses and bionanoparticles. Org Biomol Chem, 9, 6189–95
   PubMedGoogle Scholar
• Lee LA, Wang Q. (2006). Adaptations of nanoscale viruses and other protein cages for medical applications. Nanomedicine, 2, 137–49
   PubMedGoogle Scholar
• Li F, Zhang ZP, Peng J, et al. (2009). Imaging viral behavior in mammalian cells with self-assembled capsid-quantum-dot hybrid particles. Small, 5, 718–26
   PubMed Web of Science ®Google Scholar
• Liang M. (2012). Clinical development of oncolytic viruses in China. Curr Pharm Biotechnol, 13, 1852–7
   PubMed Web of Science ®Google Scholar
• Limberis MP. (2012). Phoenix rising: gene therapy makes a comeback. Acta Biochim Biophys Sin (Shanghai), 44, 632–40
   PubMedGoogle Scholar
• Liovic M, Ozir M, Bedina ZA, et al. (2012). Inclusion bodies as potential vehicles for recombinant protein delivery into epithelial cells. Microb Cell Fact, 11, 67
   PubMedGoogle Scholar
• Liu J, Zhao X. (2011). Design of self-assembling peptides and their biomedical applications. Nanomedicine (Lond), 6, 1621–43
   PubMed Web of Science ®Google Scholar
• Liu L, Busuttil K, Zhang S, et al. (2011). The role of self-assembling polypeptides in building nanomaterials. Phys Chem Chem Phys, 13, 17435–44
   PubMedGoogle Scholar
• Long BM, Badger MR, Whitney SM, Price GD. (2007). Analysis of carboxysomes from Synechococcus PCC7942 reveals multiple Rubisco complexes with carboxysomal proteins CcmM and CcaA 1. J Biol Chem, 282, 29323–35
   PubMed Web of Science ®Google Scholar
• Lunsdorf H, Gurramkonda C, Adnan A, et al. (2011). Virus-like particle production with yeast: ultrastructural and immunocytochemical insights into Pichia pastoris producing high levels of the hepatitis B surface antigen. Microb Cell Fact, 10, 48
   PubMed Web of Science ®Google Scholar
• Ma Y, Nolte RJ, Cornelissen JJ. (2012). Virus-based nanocarriers for drug delivery. Adv Drug Deliv Rev, 64, 811–25
   PubMed Web of Science ®Google Scholar
• Macnab RM. (2003). How bacteria assemble flagella. Annu Rev Microbiol, 57, 77–100
   PubMed Web of Science ®Google Scholar
• Maji SK, Schubert D, Rivier C, et al. (2008). Amyloid as a depot for the formulation of long-acting drugs. PLoS Biol, 6, e17
   PubMed Web of Science ®Google Scholar
• Manchester M, Singh P. (2006). Virus-based nanoparticles (VNPs): platform technologies for diagnostic imaging. Adv Drug Deliv Rev, 58, 1505–22
   PubMed Web of Science ®Google Scholar
• Mankar S, Anoop A, Sen S, Maji SK. (2011). Nanomaterials: amyloids reflect their brighter side. Nano Rev, 2, 6032
   PubMedGoogle Scholar
• Martin CS. (2012). Latest insights on adenovirus structure and assembly. Viruses, 4, 847–77
   PubMed Web of Science ®Google Scholar
• Mastrobattista E, van der Aa MA, Hennink WE, Crommelin DJ. (2006). Artificial viruses: a nanotechnological approach to gene delivery. Nat Rev Drug Discov, 5, 115–21
   PubMed Web of Science ®Google Scholar
• Mateu MG. (2011). Virus engineering: functionalization and stabilization. Protein Eng Des Sel, 24, 53–63
   PubMedGoogle Scholar
• McKay RM, Gibbs SP, Espie GS. (1993). Effect of dissolved inorganic carbon on the expression of carboxysomes, localization of Rubisco and the mode of inorganic carbon transport in cells of the cyanobacterium Synechococcus UTEX 625. Arch Microbiol, 159, 21–9
   Google Scholar
• Mellado MC, Mena JA, Lopes A, et al. (2009). Impact of physicochemical parameters on in vitro assembly and disassembly kinetics of recombinant triple-layered rotavirus-like particles. Biotechnol Bioeng, 104, 674–86
   PubMed Web of Science ®Google Scholar
• Menon BB, Dou Z, Heinhorst S, et al. (2008). Halothiobacillus neapolitanus carboxysomes sequester heterologous and chimeric RubisCO species. PLoS One, 3, e3570
   Google Scholar
• Morell M, Bravo R, Espargaro A, et al. (2008). Inclusion bodies: specificity in their aggregation process and amyloid-like structure. Biochim Biophys Acta, 1783, 1815–25
   PubMed Web of Science ®Google Scholar
• Nahalka J, Nidetzky B. (2007). Fusion to a pull-down domain: a novel approach of producing Trigonopsis variabilisD-amino acid oxidase as insoluble enzyme aggregates. Biotechnol Bioeng, 97, 454–61
   PubMed Web of Science ®Google Scholar
• Nisbet DR, Williams RJ. (2012). Self-assembled peptides: characterisation and in vivo response. Biointerphases, 7, 2
   PubMedGoogle Scholar
• Palomares LA, Mena JA, Ramirez OT. (2012). Simultaneous expression of recombinant proteins in the insect cell-baculovirus system: production of virus-like particles. Methods, 56, 389–95
   PubMedGoogle Scholar
• Pan Y, Zhang Y, Jia T, et al. (2012a). Development of a microRNA delivery system based on bacteriophage MS2 virus-like particles. FEBS J, 279, 1198–208
   PubMed Web of Science ®Google Scholar
• Pan Y, Zhang Y, Jia T, et al. (2012b). Development of a microRNA delivery system based on bacteriophage MS2 virus-like particles. FEBS J, 279, 1198–208
   PubMed Web of Science ®Google Scholar
• Parsons JB, Frank S, Bhella D, et al. (2010a). Synthesis of empty bacterial microcompartments, directed organelle protein incorporation, and evidence of filament-associated organelle movement. Mol Cell, 38, 305–15
   PubMed Web of Science ®Google Scholar
• Parsons JB, Frank S, Bhella D, et al. (2010b). Synthesis of empty bacterial microcompartments, directed organelle protein incorporation, and evidence of filament-associated organelle movement. Mol Cell, 38, 305–15
   PubMed Web of Science ®Google Scholar
• Pasqualini R, Ruoslahti E. (1996a). Organ targeting in vivo using phage display peptide libraries. Nature, 380, 364–6
   PubMed Web of Science ®Google Scholar
• Pasqualini R, Ruoslahti E. (1996b). Tissue targeting with phage peptide libraries. Mol Psychiatry, 1, 423
   PubMed Web of Science ®Google Scholar
• Patel KG, Swartz JR. (2011). Surface functionalization of virus-like particles by direct conjugation using azide-alkyne click chemistry. Bioconjug Chem, 22, 376–87
   PubMed Web of Science ®Google Scholar
• Pattenden LK, Middelberg AP, Niebert M, Lipin DI. (2005). Towards the preparative and large-scale precision manufacture of virus-like particles. Trends Biotechnol, 23, 523–9
   PubMed Web of Science ®Google Scholar
• Peluffo H, Acarin L, Aris A, et al. (2006). Neuroprotection from NMDA excitotoxic lesion by Cu/Zn superoxide dismutase gene delivery to the postnatal rat brain by a modular protein vector. BMC Neurosci, 7, 35
   PubMed Web of Science ®Google Scholar
• Peluffo H, Aris A, Acarin L, et al. (2003). Nonviral gene delivery to the central nervous system based on a novel integrin-targeting multifunctional protein. Hum Gene Ther, 14, 1215–23
   PubMedGoogle Scholar
• Peluffo H, li-Ruiz D, Ejarque-Ortiz A, et al. (2011). Overexpression of the immunoreceptor CD300f has a neuroprotective role in a model of acute brain injury. Brain Pathol, 22, 318–28
   PubMedGoogle Scholar
• Peternel S, Jevsevar S, Bele M, et al. (2008). New properties of inclusion bodies with implications for biotechnology. Biotechnol Appl Biochem, 49, 239–46
   PubMed Web of Science ®Google Scholar
• Plank C, Tang MX, Wolfe AR, Szoka FC, Jr. (1999). Branched cationic peptides for gene delivery: role of type and number of cationic residues in formation and in vitro activity of DNA polyplexes. Hum Gene Ther, 10, 319–32
   PubMed Web of Science ®Google Scholar
• Price GD, Badger MR. (1989). Isolation and characterization of high CO(2)-requiring-mutants of the cyanobacterium Synechococcus PCC7942: two phenotypes that accumulate inorganic carbon but are apparently unable to generate CO(2) within the carboxysome. Plant Physiol, 91, 514–25
   PubMedGoogle Scholar
• Price GD, Coleman JR, Badger MR. (1992). Association of carbonic anhydrase activity with carboxysomes isolated from the cyanobacterium Synechococcus PCC7942. Plant Physiol, 100, 784–93
   PubMedGoogle Scholar
• Price GD, Howitt SM, Harrison K, Badger MR. (1993). Analysis of a genomic DNA region from the cyanobacterium Synechococcus sp. strain PCC7942 involved in carboxysome assembly and function. J Bacteriol, 175, 2871–9
   PubMedGoogle Scholar
• Qu Q, Sawa H, Suzuki T, et al. (2004). Nuclear entry mechanism of the human polyomavirus JC virus-like particle: role of importins and the nuclear pore complex. J Biol Chem, 279, 27735–42
   PubMed Web of Science ®Google Scholar
• Raper SE, Chirmule N, Lee FS, et al. (2003). Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol Genet Metab, 80, 148–58
   PubMed Web of Science ®Google Scholar
• Rodriguez-Carmona E, Cano-Garrido O, Seras-Franzoso J, et al. (2010). Isolation of cell-free bacterial inclusion bodies. Microb Cell Fact, 9, 71
   PubMed Web of Science ®Google Scholar
• Rodriguez-Carmona E, Villaverde A. (2010). Nanostructured bacterial materials for innovative medicines. Trends Microbiol, 18, 423–30
   PubMed Web of Science ®Google Scholar
• Rodriguez-Limas WA, Tyo KE, Nielsen J, et al. (2011). Molecular and process design for rotavirus-like particle production in Saccharomyces cerevisiae. Microb Cell Fact, 10, 33
   PubMed Web of Science ®Google Scholar
• Rudner DZ, Losick R. (2010). Protein subcellular localization in bacteria. Cold Spring Harb Perspect Biol, 2, a000307
   Web of Science ®Google Scholar
• Saccardo P, Villaverde A, Gonzalez-Montalban N. (2009). Peptide-mediated DNA condensation for non-viral gene therapy. Biotechnol Adv, 27, 432–8
   PubMed Web of Science ®Google Scholar
• Sadatmousavi P, Soltani M, Nazarian R, et al. (2011). Self-assembling peptides: potential role in tumor targeting. Curr Pharm Biotechnol, 12, 1089–100
   PubMedGoogle Scholar
• Said HF, Saleh AF, Abes R, et al. (2010). Cell penetrating peptides: overview and applications to the delivery of oligonucleotides. Cell Mol Life Sci, 67, 715–26
   PubMedGoogle Scholar
• Scheffer GL, Schroeijers AB, Izquierdo MA, et al. (2000). Lung resistance-related protein/major vault protein and vaults in multidrug-resistant cancer. Curr Opin Oncol, 12, 550–6
   PubMed Web of Science ®Google Scholar
• Seebeck FP, Woycechowsky KJ, Zhuang W, et al. (2006). A simple tagging system for protein encapsulation. J Am Chem Soc, 128, 4516–7
   PubMedGoogle Scholar
• Seow Y, Wood MJ. (2009). Biological gene delivery vehicles: beyond viral vectors. Mol Ther, 17, 767–77
   PubMed Web of Science ®Google Scholar
• Seras-Franzoso J, Peebo K, Corchero JL, et al. A nanostructured bacterial bio-scaffold for the sustained bottom-up delivery of protein drugs. Nanomedicine (Lond). 2013. [Epub ahead of print]
   Google Scholar
• Shao W, Paul A, Abbasi S, et al. (2012). A novel polyethyleneimine-coated adeno-associated virus-like particle formulation for efficient siRNA delivery in breast cancer therapy: preparation and in vitro analysis. Int J Nanomedicine, 7, 1575–86
   PubMed Web of Science ®Google Scholar
• Shively JM, Ball F, Brown DH, Saunders RE. (1973). Functional organelles in prokaryotes: polyhedral inclusions (carboxysomes) of Thiobacillus neapolitanus. Science, 182, 584–6
   PubMed Web of Science ®Google Scholar
• Shively JM, Decker GL, Greenawalt JW. (1970). Comparative ultrastructure of the thiobacilli. J Bacteriol, 101, 618–27
   PubMedGoogle Scholar
• Smaglik P. (1999). Tighter watch urged on adenoviral vectors with proposal to report all ‘adverse events’. Nature, 402, 707
   PubMedGoogle Scholar
• So AK, Espie GS, Williams EB, et al. (2004). A novel evolutionary lineage of carbonic anhydrase (epsilon class) is a component of the carboxysome shell. J Bacteriol, 186, 623–30
   PubMed Web of Science ®Google Scholar
• Speed MA, Wang DI, King J. (1996). Specific aggregation of partially folded polypeptide chains: the molecular basis of inclusion body composition. Nat Biotechnol, 14, 1283–7
   PubMed Web of Science ®Google Scholar
• Steiner E, Holzmann K, Pirker C, et al. (2006). The major vault protein is responsive to and interferes with interferon-gamma-mediated STAT1 signals. J Cell Sci, 119, 459–69
   PubMed Web of Science ®Google Scholar
• Stephen AG, Raval-Fernandes S, Huynh T, et al. (2001). Assembly of vault-like particles in insect cells expressing only the major vault protein. J Biol Chem, 276, 23217–20
   PubMedGoogle Scholar
• Strable E, Finn MG. (2009). Chemical modification of viruses and virus-like particles. Curr Top Microbiol Immunol, 327, 1–21
   PubMed Web of Science ®Google Scholar
• Stubenrauch K, Gleiter S, Brinkmann U, et al. (2001). Conjugation of an antibody Fv fragment to a virus coat protein: cell-specific targeting of recombinant polyoma-virus-like particles. Biochem J, 356, 867–73
   PubMed Web of Science ®Google Scholar
• Sutter M, Boehringer D, Gutmann S, et al. (2008). Structural basis of enzyme encapsulation into a bacterial nanocompartment. Nat Struct Mol Biol, 15, 939–47
   PubMed Web of Science ®Google Scholar
• Talafova K, Hrabarova E, Chorvat DA, Nahalka J. (2013). Bacterial inclusion bodies as potential synthetic devices for pathogen recognition and a therapeutic substance release. Microb Cell Fact, 12, 16
   PubMedGoogle Scholar
• Tanaka H, Kato K, Yamashita E, et al. (2009). The structure of rat liver vault at 3.5 angstrom resolution. Science, 323, 384–8
   PubMedGoogle Scholar
• Tanaka S, Kerfeld CA, Sawaya MR, et al. (2008). Atomic-level models of the bacterial carboxysome shell. Science, 319, 1083–6
   PubMedGoogle Scholar
• Tanaka S, Sawaya MR, Yeates TO. (2010). Structure and mechanisms of a protein-based organelle in Escherichia coli. Science, 327, 81–4
   PubMed Web of Science ®Google Scholar
• Thaci B, Ulasov IV, Wainwright DA, Lesniak MS. (2011). The challenge for gene therapy: innate immune response to adenoviruses. Oncotarget, 2, 113–21
   PubMedGoogle Scholar
• Tripp BC, Lu Z, Bourque K, et al. (2001). Investigation of the ‘switch-epitope' concept with random peptide libraries displayed as thioredoxin loop fusions. Protein Eng, 14, 367–77
   PubMedGoogle Scholar
• Ullenhag G, Loskog ASI. (2012). AdCD40L – crossing the valley of death? Int Rev Immunol, 31, 289–98
   PubMed Web of Science ®Google Scholar
• Unzueta U, Cespedes MV, Ferrer-Miralles N, et al. (2012a). Intracellular CXCR4+ cell targeting with T22-empowered protein-only nanoparticles. Int J Nanomedicine, 7, 4533–44
   PubMed Web of Science ®Google Scholar
• Unzueta U, Ferrer-Miralles N, Cedano J, et al. (2012b). Non-amyloidogenic peptide tags for the regulatable self-assembling of protein-only nanoparticles. Biomaterials, 33, 8714–22
   PubMedGoogle Scholar
• Valdes-Stauber N, Scherer S. (1994). Isolation and characterization of Linocin M18, a bacteriocin produced by Brevibacterium linens. Appl Environ Microbiol, 60, 3809–14
   PubMed Web of Science ®Google Scholar
• Vazquez E, Corchero JL, Burgueno JF, et al. (2012). Functional inclusion bodies produced in bacteria as naturally occurring nanopills for advanced cell therapies. Adv Mater, 24, 1742–7
   PubMed Web of Science ®Google Scholar
• Vazquez E, Corchero JL, Villaverde A. (2011). Post-production protein stability: trouble beyond the cell factory. Microb Cell Fact, 10, 60
   PubMed Web of Science ®Google Scholar
• Vazquez E, Cubarsi R, Unzueta U, et al. (2010a). Internalization and kinetics of nuclear migration of protein-only, arginine-rich nanoparticles. Biomaterials, 31, 9333–9
   PubMedGoogle Scholar
• Vazquez E, Ferrer-Miralles N, Mangues R, et al. (2009). Modular protein engineering in emerging cancer therapies. Curr Pharm Des, 15, 893–916
   PubMed Web of Science ®Google Scholar
• Vazquez E, Ferrer-Miralles N, Villaverde A. (2008). Peptide-assisted traffic engineering for nonviral gene therapy. Drug Discov Today, 13, 1067–74
   PubMed Web of Science ®Google Scholar
• Vazquez E, Roldan M, Diez-Gil C, et al. (2010b). Protein nanodisk assembling and intracellular trafficking powered by an arginine-rich (R9) peptide. Nanomedicine (Lond), 5, 259–68
   PubMedGoogle Scholar
• Vazquez E, Villaverde A. (2010). Engineering building blocks for self-assembling protein nanoparticles. Microb Cell Fact, 9, 101
   PubMed Web of Science ®Google Scholar
• Villar-Pique A, Espargaro A, Sabate R, et al. (2012). Using bacterial inclusion bodies to screen for amyloid aggregation inhibitors. Microb Cell Fact, 11, 55
   PubMed Web of Science ®Google Scholar
• Villar-Pique A, Ventura S. (2012). Modeling amyloids in bacteria. Microb Cell Fact, 11, 166
   PubMedGoogle Scholar
• Villaverde A. (2012). Bacterial inclusion bodies: an emerging platform for drug delivery and cell therapy. Nanomedicine (Lond), 7, 1277–9
   PubMedGoogle Scholar
• Villaverde A, Garcia-Fruitos E, Rinas U, et al. (2012). Packaging protein drugs as bacterial inclusion bodies for therapeutic applications. Microb Cell Fact, 11, 76
   PubMed Web of Science ®Google Scholar
• Wagner E. (2004). Strategies to improve DNA polyplexes for in vivo gene transfer: will “artificial viruses” be the answer? Pharm Res, 21, 8–14
   PubMed Web of Science ®Google Scholar
• Westerlund-Wikstrom B. (2000). Peptide display on bacterial flagella: principles and applications. Int J Med Microbiol, 290, 223–30
   PubMed Web of Science ®Google Scholar
• Wu W, Xing L, Zhou B, Lin Z. (2011). Active protein aggregates induced by terminally attached self-assembling peptide ELK16 in Escherichia coli. Microb Cell Fact, 10, 9
   PubMed Web of Science ®Google Scholar
• Yang YL, Khoe U, Wang XM, et al. (2009). Designer self-assembling peptide nanomaterials. Nano Today, 4, 193–210
   Web of Science ®Google Scholar
• Yeates TO, Crowley CS, Tanaka S. (2010a). Bacterial microcompartment organelles: protein shell structure and evolution. Annu Rev Biophys, 39, 185–205
   PubMed Web of Science ®Google Scholar
• Yeates TO, Crowley CS, Tanaka S. (2010b). Bacterial microcompartment organelles: protein shell structure and evolution. Annu Rev Biophys, 39, 185–205
   PubMed Web of Science ®Google Scholar
• Yla-Herttuala S. (2012). Endgame: glybera finally recommended for approval as the first gene therapy drug in the European union. Mol Ther, 20, 1831–2
   PubMed Web of Science ®Google Scholar
• Yonekura K, Maki-Yonekura S, Namba K. (2003). Complete atomic model of the bacterial flagellar filament by electron cryomicroscopy. Nature, 424, 643–50
   PubMed Web of Science ®Google Scholar
• Yoo JW, Irvine DJ, Discher DE, Mitragotri S. (2011). Bio-inspired, bioengineered and biomimetic drug delivery carriers. Nat Rev Drug Discov, 10, 521–35
   PubMed Web of Science ®Google Scholar
• Yu JW, Price GD, Song L, Badger MR. (1992). Isolation of a putative carboxysomal carbonic anhydrase gene from the cyanobacterium Synechococcus PCC7942. Plant Physiol, 100, 794–800
   PubMed Web of Science ®Google Scholar
• Zhao Q, Chen W, Chen Y, et al. (2011). Self-assembled virus-like particles from rotavirus structural protein VP6 for targeted drug delivery. Bioconjug Chem, 22, 346–52
   PubMed Web of Science ®Google Scholar
• Zhou B, Xing L, Wu W, et al. (2012). Small surfactant-like peptides can drive soluble proteins into active aggregates. Microb Cell Fact, 11, 10
   PubMed Web of Science ®Google Scholar